+ Follow ROCHE GROUP Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 687129
[Title] => Roche partners with Merck vs chronic hepatitis C
[Summary] => Roche has announced that it has entered into agreements with Merck, known as MSD outside the United States, through their respective subsidiaries, to improve the treatment, diagnosis and awareness of chronic hepatitis C (HCV) infection in the United States.
[DatePublished] => 2011-05-19 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 663669
[Title] => Roche approves dividend hike of 10%
[Summary] => Roche’s annual general meeting last March 1 has approved all of the board of directors’ proposals.
[DatePublished] => 2011-03-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[2] => Array
(
[ArticleID] => 626491
[Title] => Extending the life of people with lung cancer
[Summary] => MILAN, Italy — Roche has released new data for its new investigational compound at the 35th European Society for Medical Oncology (ESMO) congress showing significant progress for people living with lung cancer.
[DatePublished] => 2010-11-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 605430
[Title] => Roche acquires Biolmagene for $100 million
[Summary] => Roche announced that it has signed an agreement under which Ventana Medical Systems Inc., a member of the Roche Group, will acquire 100 percent of BioImagene, Inc., a privately held company based in Sunnyvale, California.
[DatePublished] => 2010-08-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[4] => Array
(
[ArticleID] => 560018
[Title] => Roche poised for long-term growth
[Summary] => Roche is set to strengthen its global leadership position in oncology and to expand in therapeutic areas such as metabolism, inflammation and diseases of the central nervous system.
[DatePublished] => 2010-03-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
ROCHE GROUP
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 687129
[Title] => Roche partners with Merck vs chronic hepatitis C
[Summary] => Roche has announced that it has entered into agreements with Merck, known as MSD outside the United States, through their respective subsidiaries, to improve the treatment, diagnosis and awareness of chronic hepatitis C (HCV) infection in the United States.
[DatePublished] => 2011-05-19 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 663669
[Title] => Roche approves dividend hike of 10%
[Summary] => Roche’s annual general meeting last March 1 has approved all of the board of directors’ proposals.
[DatePublished] => 2011-03-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[2] => Array
(
[ArticleID] => 626491
[Title] => Extending the life of people with lung cancer
[Summary] => MILAN, Italy — Roche has released new data for its new investigational compound at the 35th European Society for Medical Oncology (ESMO) congress showing significant progress for people living with lung cancer.
[DatePublished] => 2010-11-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 605430
[Title] => Roche acquires Biolmagene for $100 million
[Summary] => Roche announced that it has signed an agreement under which Ventana Medical Systems Inc., a member of the Roche Group, will acquire 100 percent of BioImagene, Inc., a privately held company based in Sunnyvale, California.
[DatePublished] => 2010-08-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[4] => Array
(
[ArticleID] => 560018
[Title] => Roche poised for long-term growth
[Summary] => Roche is set to strengthen its global leadership position in oncology and to expand in therapeutic areas such as metabolism, inflammation and diseases of the central nervous system.
[DatePublished] => 2010-03-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
abtest
November 4, 2010 - 12:00am
August 25, 2010 - 12:00am
